Combination of Ivermectin-Mebendazole Considered for Off-Label Anti-neoplastic Effects

Combination of Ivermectin-Mebendazole Considered for Off-Label Anti-neoplastic Effects

Dr. McCullough told Grant Stinchfield that when patients have exhausted all conventional cancer treatment, patients and doctors are considering this combination. Large prospective, randomized, double blind clinical trials are warranted in common cancers.